Updates

Accesso

December 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Accesso has acquired the ShoWare online ticketing platform for US$33m in cash and shares. ShoWare is used by 475 event and entertainment venues in North and South America and complements the Accesso Passport and Siriusware ticketing solutions, which target large venues whilst ShoWare is typically used by small venues including casinos, fairs, sporting events, arenas and theatres where assigned seating is a key component of the visitor experience. In 2013, ShoWare processed the sale of 19 million tickets and with a model priced on a per-ticket basis, it generated sales of US$7.7m and an operating profit of US$2.7m. Canaccord has upgraded next year’s forecast by 12% to US$11.6m for eps of 32.3 cents. Accesso is slowly but ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Parkmead - Son of Dana

Conviviality Retail

Accesso (March 2019)

Accesso (May 2017)

Accesso - Still flying high - gain now 175% (November 2016)

Accesso - Strong visibility through to 2022 (April 2016)

Accesso (March 2016)

Accesso - Huge contract win with Merlin Entertainments (September 2015)

Accesso (October 2014)

Accesso (April 2014)

Accesso (December 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X